CAMBRIDGE, Mass., Oct. 4, 2018 /PRNewswire-PRWeb/ -- People who experience two or more migraine attacks per month can register for a FREE premium subscription to N1-Headache through December 31, 2018. Previously only available for iOS devices, N1-Headache is now also available for Android devices.
This free offer is being extended through Curelator's partnerships with:
THE MIGRAINE TRUST, a patient focused, research driven charity in the United Kingdom.
UK residents may register for a free premium subscription to N1-Headache through this link at Migraine Trust: https://www.migrainetrust.org/n1headache/
MIGRAINE ASSOCIATION OF IRELAND, a registered charity dedicated to improving the quality of life for those with migraine and other headache disorders.
Irish residents may register through Migraine Association of Ireland through this link: https://www.migraine.ie/n1headache-freeaccess/
NATIONAL HEADACHE FOUNDATION (NHF), a 48-year old nonprofit based in Chicago, Illinois, dedicated to furthering awareness and education of headache and migraine.
U.S. residents may register through National Headache Foundation through this link: https://headaches.org/2018/09/13/manage-migraine-with-free-app/
In return for the FREE subscription, Curelator will ask participants for feedback about their experience via a brief questionnaire after three months use of N1-Headache.
About Curelator Inc. and N1-Headache
Curelator is a digital health company focused on developing clinical grade disease management platforms for patients and clinicians. N1-Headache™ is a unique analytical tool for people with a history of migraine or medication overuse. Premium subscribers (including those using the free offer) receive a Personal Analytical Report containing individualized migraine 'Trigger', 'Protector' and 'No Association' maps after 90 days of data entry. This personalized information enables patients and their healthcare providers to manage individual migraine risk factors, assess therapeutic response to drugs and identify opportunities to prevent medication overuse.